Avalon GloboCare Corp. (NASDAQ:ALBT) Short Interest Update

Avalon GloboCare Corp. (NASDAQ:ALBT) saw a significant decline in short interest in the month of March. As of March 15th, there was short interest totalling 23,800 shares, a decline of 47.6% from the February 28th total of 45,400 shares. Based on an average trading volume of 86,600 shares, the short-interest ratio is presently 0.3 days. Approximately 5.6% of the shares of the company are short sold.

Avalon GloboCare Trading Down 0.9 %

NASDAQ:ALBT opened at $5.27 on Friday. The stock has a 50 day moving average of $5.12 and a 200-day moving average of $3.94. The firm has a market capitalization of $5.77 million, a PE ratio of -0.26 and a beta of -0.10. Avalon GloboCare has a 52 week low of $2.11 and a 52 week high of $21.60.

About Avalon GloboCare

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and China. The company develops and delivers transformative cellular therapeutics, precision diagnostics, and clinical laboratory services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells.